Ustekinumab news

All news on Ustekinumab (also known as STELARA®): plants, production capacities, investments and involved companies.

31 October 2025
Johnson & Johnson Seeks FDA Approval for STELARA in Pediatric Ulcerative Colitis
sBLA submitted for STELARA to treat pediatric ulcerative colitis, backed by Phase 3 UNIFI Jr trial data, aiming to expand treatment options for children.

Who will be producing Ustekinumab in the future?

Find out with chemXplore Analytics